Tag: Targeted oncology

Browse exclusive Tags!

Clinical-Stage Immunotherapy Company, Checkpoint Therapeutics, Announces $11.13M Warrant Exercise Offering, US

Checkpoint Therapeutics announces $11.13M warrant exercise offering for targeted oncology treatments.

Relay Therapeutics to Report Q2 2023 Financial Results and Highlights on August 8, United States (US)

Relay Therapeutics, a clinical-stage precision medicine company, announces Q2 2023 financial results & advancements in drug discovery using advanced technologies.

Popular

Relay Therapeutics to Report Q2 2023 Financial Results and Highlights on August 8, United States (US)

Relay Therapeutics, a clinical-stage precision medicine company, announces Q2 2023 financial results & advancements in drug discovery using advanced technologies.

Subscribe

spot_imgspot_img